Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary

por Samardzija, Chantel, Quinn, Michael, Findlay, Jock K, Ahmed, Nuzhat
Publicado 2012

Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment

por Escalona, Ruth M., Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado 2022

Estrogen-Dependent Gene Expression in the Mouse Ovary

por Liew, Seng H., Sarraj, Mai A., Drummond, Ann E., Findlay, Jock K.
Publicado 2011

The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression

por Escalona, Ruth M., Chan, Emily, Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado 2018

Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer

por Kadife, Elif, Chan, Emily, Luwor, Rodney, Kannourakis, George, Findlay, Jock, Ahmed, Nuzhat
Publicado 2019

Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer

por Ahmed, Nuzhat, Latifi, Ardian, Riley, Clyde B, Findlay, Jock K, Quinn, Michael A
Publicado 2010

Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer

por Chan, Emily, Luwor, Rodney, Burns, Christopher, Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado 2018

The ovarian reserve is depleted during puberty in a hormonally driven process dependent on the pro-apoptotic protein BMF

por Liew, Seng H, Nguyen, Quynh-Nhu, Strasser, Andreas, Findlay, Jock K, Hutt, Karla J
Publicado 2017

A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer

por Samardzija, Chantel, Luwor, Rodney B, Volchek, Mila, Quinn, Michael A, Findlay, Jock K, Ahmed, Nuzhat
Publicado 2015

Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer

por Samardzija, Chantel, Luwor, Rodney B., Quinn, Michael A., Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado 2016

HTRA3 expression in non-pregnant rhesus monkey ovary and endometrium, and at the maternal-fetal interface during early pregnancy

por Bowden, Marissa A, Li, Ying, Liu, Yi-Xun, Findlay, Jock K, Salamonsen, Lois A, Nie, Guiying
Publicado 2008

Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells

por Ahmed, Nuzhat, Greening, David, Samardzija, Chantel, Escalona, Ruth M., Chen, Maoshan, Findlay, Jock K., Kannourakis, George
Publicado 2016

TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells

por Escalona, Ruth M., Bilandzic, Maree, Western, Patrick, Kadife, Elif, Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado 2020

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

por Escalona, Ruth M., Chu, Simon, Kadife, Elif, Kelly, Jason K., Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado 2022

Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling

por Samardzija, Chantel, Greening, David W., Escalona, Ruth, Chen, Maoshan, Bilandzic, Maree, Luwor, Rodney, Kannourakis, George, Findlay, Jock K., Ahmed, Nuzhat
Publicado 2017

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden

por Abubaker, Khalid, Latifi, Ardian, Luwor, Rod, Nazaretian, Simon, Zhu, Hongjian, Quinn, Michael A, Thompson, Erik W, Findlay, Jock K, Ahmed, Nuzhat
Publicado 2013

Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor...

por Abubaker, Khalid, Luwor, Rodney B., Escalona, Ruth, McNally, Orla, Quinn, Michael A., Thompson, Erik W., Findlay, Jock K., Ahmed, Nuzhat
Publicado 2014

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

por Abubaker, Khalid, Luwor, Rodney B, Zhu, Hongjian, McNally, Orla, Quinn, Michael A, Burns, Christopher J, Thompson, Erik W, Findlay, Jock K, Ahmed, Nuzhat
Publicado 2014

Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility

por Nguyen, Quynh-Nhu, Zerafa, Nadeen, Liew, Seng H., Morgan, F. Hamish, Strasser, Andreas, Scott, Clare L., Findlay, Jock K., Hickey, Martha, Hutt, Karla J.
Publicado 2018

Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors

por Latifi, Ardian, Luwor, Rodney B., Bilandzic, Maree, Nazaretian, Simon, Stenvers, Kaye, Pyman, Jan, Zhu, Hongjian, Thompson, Erik W., Quinn, Michael A., Findlay, Jock K., Ahmed, Nuzhat
Publicado 2012